NORTHERN TRUST CORP

Bank

Position in SRZN — Surrozen, Inc./DE

CIK 73124 CHICAGO, IL

Position in SRZN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,650,653

+$1,293,374 QoQ

Shares Held

63,609

+418.6% QoQ

Ownership

0.541%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 70 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 98% Shared 2% None 0%

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,812,079,440 across 423 Biotechnology names. SRZN ranks #240 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,486,478	$1,235,108,212
2	REGN	Regeneron Pharmaceuticals, Inc.	916,467	$571,453,829
3	ALNY	Alnylam Pharmaceuticals, Inc.	886,900	$266,983,504
4	RPRX	Royalty Pharma plc	4,718,859	$264,586,419
5	RVMD	Revolution Medicines, Inc.	1,117,110	$209,212,357
6	MRNA	Moderna, Inc.	2,985,329	$209,062,587
7	INCY	Incyte Corp	1,761,966	$199,736,460
8	CYTK	Cytokinetics Inc	1,647,345	$140,337,319

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,650,653	63,609	+418.6%	Shares	Other	2026-08-13
2026-03-31	$357,279	12,265	-9.3%	Shares	Defined	2026-05-14
2025-12-31	$305,778	13,530	-62.2%	Shares	Defined	2026-02-17
2023-09-30	$17,558	35,833	0.0%	Shares	Defined	2023-11-13
2023-06-30	$19,708	35,833	0.0%	Shares	Defined	2023-08-11
2023-03-31	$21,571	35,833	0.0%	Shares	Defined	2023-05-15
2022-12-31	$20,854	35,833	0.0%	Shares	Defined	2023-02-13
2022-09-30	$72,382	35,833	0.0%	Shares	Defined	2022-11-14
2022-06-30	$107,499	35,833	-5.7%	Shares	Defined	2022-08-12
2022-03-31	$114,343	37,988	0.0%	Shares	Defined	2022-05-13
2021-12-31	$244,642	37,988	0.0%	Shares	Defined	2022-02-08
2021-09-30	$268,955	37,988	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.